Reporting adverse drug reactions
As part of our medicinal products safety oversight, we continuously monitor the safety of our products. Information from patients about their therapeutic experiences is extremely valuable to us. This knowledge supports ongoing assessment of the safety profile of medicines and enables us to take actions to minimize side effects of therapy, thereby improving patient safety in the use of medicines.
If an adverse reaction occurs after using a SciencePharma product, it can be reported to our Pharmacovigilance Department. Reports can be submitted by phone or by sending a completed form via email, fax, or post to:
SciencePharma spółka z ograniczoną odpowiedzialnością
ul. Chełmska 30/34
00-725 Warszawa
Tel.: + 48 (22) 841 16 64
Tel. 24 h: +48 604 44 66 58
e-mail: phv@sciencepharma.pl
Download form
We also encourage reporting the use of our product during pregnancy
The controller of the personal data provided in the form is SciencePharma Spółka z ograniczoną odpowiedzialnością, ul. Chełmska 30/34, 00-725 Warsaw. For contact with the Controller, correspondence should be sent to: ado@sciencepharma.pl. Your personal data is processed on the basis of Article 6(1)(c) and Article 9(2)(i) of the General Data Protection Regulation (GDPR, EU 2016/679 of 27 April 2016). The data provided is processed solely for the purpose of fulfilling obligations related to monitoring the safety of medicinal products in accordance with Regulation (EU) No 520/2012 of 19 June 2012. Providing the data of the reporting person is necessary to accept the report. The recipients of your personal data will only be entities authorized to obtain personal data under applicable law. You have the right to access your data and the right to correct it. Your personal data will be stored for the entire period during which the medicinal product is authorized for marketing and for 10 years after the authorization expires. You have the right to lodge a complaint with the President of the Personal Data Protection Office if you believe that the processing of your personal data violates GDPR provisions.